0I0X Stock Overview
Codexis, Inc. discovers, develops, and sells enzymes and other proteins.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Codexis, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.80 |
| 52 Week High | US$4.87 |
| 52 Week Low | US$1.47 |
| Beta | 2.03 |
| 1 Month Change | -19.01% |
| 3 Month Change | 5.47% |
| 1 Year Change | -30.62% |
| 3 Year Change | -87.86% |
| 5 Year Change | -87.23% |
| Change since IPO | -68.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0I0X | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | 1.3% | 1.9% | 2.3% |
| 1Y | -30.6% | -41.7% | 0.6% |
Price Volatility
| 0I0X volatility | |
|---|---|
| 0I0X Average Weekly Movement | 16.9% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 174 | Stephen Dilly | www.codexis.com |
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services.
Codexis, Inc. Fundamentals Summary
| 0I0X fundamental statistics | |
|---|---|
| Market cap | US$203.88m |
| Earnings (TTM) | -US$76.24m |
| Revenue (TTM) | US$70.14m |
2.8x
P/S Ratio-2.6x
P/E RatioIs 0I0X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0I0X income statement (TTM) | |
|---|---|
| Revenue | US$70.14m |
| Cost of Revenue | US$71.69m |
| Gross Profit | -US$1.55m |
| Other Expenses | US$74.69m |
| Earnings | -US$76.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -1.08 |
| Gross Margin | -2.21% |
| Net Profit Margin | -108.69% |
| Debt/Equity Ratio | 0% |
How did 0I0X perform over the long term?
See historical performance and comparison